ReviewClinical reviews in allergy & immunology2022

Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis.

Milena Marzęcka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.